Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report) General Counsel Mitchell Gendel purchased 2,500 shares of the business's stock in a transaction that occurred on Thursday, August 6th. The stock was bought at an average cost of $4.43 per share, with a total value of $11,075.00. Following the acquisition, the general counsel owned 124,883 shares of the company's stock, valued at approximately $553,231.69. The trade was a 2.04% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Tilray Brands Trading Up 2.6%
Shares of Tilray Brands stock traded up $0.12 during trading hours on Friday, hitting $4.55. The company's stock had a trading volume of 1,216,789 shares, compared to its average volume of 4,317,777. The stock has a market cap of $530.89 million, a price-to-earnings ratio of -4.23 and a beta of 1.90. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.37 and a current ratio of 2.21. Tilray Brands, Inc. has a twelve month low of $3.67 and a twelve month high of $23.20. The firm has a fifty day moving average of $4.60 and a 200-day moving average of $6.09.
Tilray Brands (NASDAQ:TLRY - Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.42). Tilray Brands had a negative net margin of 13.11% and a negative return on equity of 7.76%. The company had revenue of $281.71 million during the quarter, compared to analysts' expectations of $246.30 million. Research analysts forecast that Tilray Brands, Inc. will post -0.4 EPS for the current year.
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on TLRY shares. Wall Street Zen cut shares of Tilray Brands from a "hold" rating to a "sell" rating in a research report on Saturday, August 1st. Weiss Ratings lowered Tilray Brands from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Wednesday, May 13th. TD Securities raised Tilray Brands to a "strong-buy" rating in a research note on Friday, July 31st. Finally, TD Cowen dropped their price objective on Tilray Brands from $7.00 to $5.00 and set a "buy" rating for the company in a research note on Tuesday, July 14th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Tilray Brands currently has a consensus rating of "Moderate Buy" and a consensus target price of $11.00.
Get Our Latest Research Report on TLRY
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the business. Hilton Head Capital Partners LLC acquired a new position in shares of Tilray Brands in the fourth quarter worth $38,000. Essential Partners LLC increased its position in shares of Tilray Brands by 110,137.5% during the first quarter. Essential Partners LLC now owns 8,819 shares of the company's stock worth $57,000 after acquiring an additional 8,811 shares during the period. Engineers Gate Manager LP acquired a new stake in Tilray Brands in the 4th quarter valued at about $126,000. R Squared Ltd purchased a new position in Tilray Brands in the first quarter worth approximately $94,000. Finally, Apollon Wealth Management LLC purchased a new stake in shares of Tilray Brands during the 1st quarter worth $96,000. Institutional investors and hedge funds own 9.35% of the company's stock.
About Tilray Brands
(
Get Free Report)
Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.
Tilray's product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.